 |
||||
|
What are MTAs? Why do we have them? How long does it take? What's the Procedure?
Forms
Material Transfer Agreements (MTAs) are written agreements that govern the exchange of research materials and drug compounds among scientists at academic institutions and at companies.
In return for providing their material, companies typically want academic recipients to grant intellectual property rights to the company for discoveries made with their material. Companies also want an opportunity to review your research data generated with their material before a manuscript containing the data is submitted to a journal for publication. Academic institutions sometimes want to restrict you from using the material in research funded by a company and from disclosing the provider scientist's unpublished research results (which may accompany the material). To protect their material, both company and academic MTAs prohibit you from distributing the material to anyone outside your lab. Once you've submitted a PI Questionnaire (see below), MTAs from academic institutions are approved usually in a few weeks, as the requests of academic providers seldom conflict with your objectives as the recipient scientist. Company MTAs can take longer since many companies seek terms that are contrary to Brigham and NIH policies. The terms of all MTAs are negotiated by CSRL on your behalf to resolve the issues of:
Materials Transfer in Academia. www.cogr.edu/mta.htm 1. Receiving materials from a company: If you have requested materials from a company and the company has sent you an MTA, forward it to us at CSRL via interoffice mail. In addition, complete the form PI Questionnaire:Receiving Materials and electronically submit it to CSRL. No MTA will be reviewed without a fully completed form, and only CSRL can sign the MTA. 2. Receiving materials from an academic institution: If you have requested materials from an academic institution and they have sent you an MTA, forward it to us via interoffice mail. In addition, complete the form PI Questionnaire:Receiving Materials and electronically submit it to CSRL. No MTA will be reviewed without a fully completed form. 3. Sending materials to academic colleagues Both the NIH and CSRL encourage you to send materials to your academic colleagues. However, if the materials you wish to share were made with commercial funding or with materials from a third party, you may have obligations to the company or third party that prohibit you from transferring them.
b. Were the materials the subject of a license to a company? c. Were the materials developed using, or derived from, other material (e.g. plasmid, mice, compound, or genechip) that you, or another hospital employee, received from an academic or commercial party under an MTA or other written agreement? If the answers to the above questions were "no", please fill out the PI Questionnaire: Sending Materials and electronically submit it to CSRL. CSRL will then send you a concise Simple Letter Agreement written by the NIH, for you to forward to the recipient to sign. If, the answer to any of the above questions was "yes", please complete the PI Questionnaire: Sending Materials and electronically submit it to CSRL. A representative from CSRL will contact you within one day to discuss whether it is permissible to transfer the material, and if so, will draft an appropriate MTA. 4. Sending materials to corporate colleagues Please complete PI Questionnaire: Sending Materials and electronically submit it to the CSRL office. A representative from CSRL will draft an MTA appropriate for your purposes. When the company returns the signed MTA to CSRL, CSRL will notify you to send out the materials. |
||||
